Quick Answer
Aptevo Therapeutics Inc. reported Net Income of -$25.97 million for fiscal year 2025.
Aptevo Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$25.97M | -7.6% |
| 2024 | -$24.13M | -38.6% |
| 2023 | -$17.41M | -316.9% |
| 2022 | $8.03M | +128.2% |
| 2021 | -$28.46M | -60.3% |
| 2020 | -$17.75M | +56.1% |
| 2019 | -$40.45M | +24.7% |
| 2018 | -$53.69M | -870.0% |
| 2017 | $6.97M | +106.2% |
| 2016 | -$112.42M | -89.5% |
| 2015 | -$59.32M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.55M | -48.0% | -21.7% |
| June 30, 2025 | -$6.20M | -5.5% | +3.2% |
| March 31, 2025 | -$6.41M | +6.2% | -25.6% |
| September 30, 2024 | -$5.10M | +19.5% | +13.3% |
| June 30, 2024 | -$5.88M | +26.0% | +13.9% |
| March 31, 2024 | -$6.83M | -346.4% | -7.9% |
| September 30, 2023 | -$6.33M | +17.1% | +20.3% |
| June 30, 2023 | -$7.95M | -128.4% | -386.6% |
- Aptevo Therapeutics Inc. showed a decrease of -7.6% in Net Income compared to the prior fiscal year.
- Over the 2015–2025 period, Aptevo Therapeutics Inc.’s net income has grown by 56.2% (from -$59.32 million to -$25.97 million).
- The most recent figure is from Aptevo Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: